phosphodiesterase 11A (PDE11A) (C-Term) Peptid
PDE11A
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PDE11A Produkte
- PDE11A (phosphodiesterase 11A (PDE11A))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- VTSEFFEQGD RERLELKLTP SAIFDRNRKD ELPRLQLEWI DSICMPLYQA
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PDE11A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDE11A (phosphodiesterase 11A (PDE11A))
- Hintergrund
-
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia.
Alias Symbols: FLJ23693, MGC133355, MGC133356, PPNAD2
Protein Size: 489 - Molekulargewicht
- 56 kDa
- Gen-ID
- 50940
- NCBI Accession
- NM_001077196, NP_001070664
-
Sie sind hier:
